Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study
NCT02424994 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12464
Last updated 2015-04-23
Summary
The aim of this project is to study the association of a number of demographic and cardiovascular risk factors with death, health care utilisation and systemic embolisation by examining the clinical evolution of hypertrophic cardiomyopathy in a large, community based cohort identified from linked electronic health records.
Conditions
Interventions
- OTHER
-
No intervention
Sponsors & Collaborators
-
Inherited Cardiac Diseases Unit, The Heart Hospital, London
collaborator UNKNOWN -
University College, London
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Guideline Recommended Care and Excess Mortality for Non ST-elevation Myocardial Infarction : A National Cohort Study
NCT02436187 ·Status: COMPLETED
-
Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy
NCT03726424 ·Status: UNKNOWN
-
Identification of Prognostic Parameters in Patients With " Senile " Amyloid Cardiomyopathy
NCT04225754 ·Status: UNKNOWN
-
The Heart Hive - Cardiomyopathy Study
NCT04612296 ·Status: RECRUITING
-
Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19)
NCT04641988 ·Status: COMPLETED
-
Myocardial Ischemia Without Obstructive Coronary Stenoses
NCT04827498 ·Status: RECRUITING
-
A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
NCT00971828 ·Status: COMPLETED
-
Carotid Atherosclerosis Follow-up Study
NCT00005189 ·Status: COMPLETED
-
Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndrome (ACS)
NCT00442949 ·Status: COMPLETED ·Phase: NA
-
Evaluation of HEArt invoLvement in Patients With FABRY Disease
NCT03362164 ·Status: RECRUITING
-
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy
NCT06169358 ·Status: RECRUITING
-
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
NCT06813443 ·Status: RECRUITING
-
Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
NCT01198899 ·Status: COMPLETED
-
Observational Study for Patients With Hypertrophic Cardiomyopathy
NCT04851652 ·Status: RECRUITING
-
CVD Risk Profile in Children With HCM
NCT05510180 ·Status: COMPLETED
-
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
NCT01915615 ·Status: ACTIVE_NOT_RECRUITING
-
Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
NCT02221141 ·Status: COMPLETED
-
Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy
NCT01671696 ·Status: COMPLETED
-
Breath-hold Cardiac Hybrid SPECT/CCTA
NCT02469051 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Fabry Disease: Impact of an Educational Brochure Intended for Cardiologist
NCT02883205 ·Status: UNKNOWN
-
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
NCT03843255 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence of Ascending Aortic Dilation in Sports Medicine
NCT07050953 ·Status: COMPLETED
-
Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography
NCT02500420 ·Status: UNKNOWN ·Phase: NA
-
CARdiomyopathy in Type 2 DIAbetes Mellitus
NCT04303364 ·Status: ACTIVE_NOT_RECRUITING
-
Monitoring Radiation Induced Cardiac Damage by Blood Markers
NCT02481778 ·Status: COMPLETED